Abstract We report a case of metastatic papillary thyroid carcinoma and undifferentiated nonkeratinizing nasopharyngeal carcinoma to the same cervical lymph node following chemotherapy for mantle cell lymphoma. Total thyroidectomy, right cervical nodal dissection, radioactive iodine-131 therapy and radiotherapy to the nasopharynx and the neck resulted in remission of both tumors. No recurrence was noted in follow-up for 48 months.
processing cleft artifact could be seen in both of them. The PTC and most of the metastases in the right cervical lymph nodes were positive for CK7, CK19, GST, thyroglobulin, TTF-1, ret oncoprotein and Galectin-3. The metastatic UNC was negative for these antibodies and calretinin, but positive for CK5/6, CK8/18 and EMA immunostains. PTC with metastases in cervical lymph nodes was diagnosed on histologic examination. In addition, one of the lymph nodes showed both metastatic PTC and UNC. Radioactive thyroid I 131 imaging revealed no thyroid tissue in other parts of the body. Magnetic resonance imaging (MRI) of the nasopharynx was recommended. MRI scan showed thickening of the right nasopharyngeal mucosa with a 1.7 9 1.5 cm soft tissue mass and small lymph nodes in parapharyngeal spaces and posterior cervical triangle. There was no invasion of the base of the skull (Fig. 5) . Biopsy of the right nasopharynx showed UNC (Fig. 6) , similar in morphology to the metastatic carcinoma in the lymph node and positive for CK5/6, CK8/ 18, and EMA immunostains. The tumor cells were negative for EBV small RNA (EBER1) and EBV oncogene latent membrane protein-1 (EBV LMP-1, PNA ISH Detection Kit, Dako Cytomation, Denmark). The thyroid carcinoma was staged as T3N1M0, Stage 1 (by AJCC in 2002). Postoperatively, radioactive iodine-131 therapy was administered twice, followed by oral thyroxine therapy. For the nasopharyngeal carcinoma (T1N2M0, stage 3, AJCC), 6 MV-X ray radiotherapy with dosage of 70 Gy/30 sessions over 7 weeks to nasopharynx, and 60 Gy/30 sessions over 6 weeks to metastatic cervical lymph nodes was initiated.
Complete remission was noted after radiotherapy. Follow-up examination every 3 months showed no recurrence or metastases 48 months after diagnosis of nasopharyngeal carcinoma. Thyroid carcinoma with follicular and papillary structures, psammoma bodies (arrow), ground-glass like nuclei, nuclear grooves, intra-nuclear pseudo inclusion bodies and overlapping nuclei. H&E 9 100 Fig. 3 Mantle cell lymphoma after chemotherapy cured, lymphoid follicles collapse, lymphatic sinus atrophy, fibrosis. The remnants of Lymphoid tissue and reactive hyperplasia of fibrous tissue appear around UNC (small arrow) and PTC (large arrow). H&E 9 20 Fig. 4 The remnants of lymphocytes and a small amount of fibrous tissue hyperplasia present between UNC (small arrow) and PTC (large arrow). There is collapse of lymphoid follicles beside the undifferentiated carcinoma. H&E 9 100
Discussion
Mantle cell lymphoma is a relatively rare lymphoma [1] and is generally associated with poor prognosis. Thyroid carcinoma is the most common endocrine malignancy and accounts for about 1 % of all cancers [2] . Nasopharyngeal carcinoma is a fairly common malignant tumor in South China, particularly in Guangdong province [3] , with an incidence of 10-20 cases per 100,000 in the male population, and presenting mostly with enlarged cervical nodules [3] [4] [5] . Among all metastatic cancers in cervical lymph nodes, 1 % to 9 % are of unknown origin [6, 7] . When both adenocarcinoma and squamous carcinoma appear in the same lymph node, it is very difficult to determine their histological origins. The squamoid focus in the lymph node in question could potentially represent (1) mesothelial nests in the lymph node, (2) squamous metaplasia accompanying metastatic papillary carcinoma, or (3) separate synchronous metastasis from nasopharyngeal carcinoma. As these cells were negative for calretinin immunostain and as the nasopharyngeal carcinoma and the metastatic undifferentiated carcinoma in the lymph node had similar morphology and immunohistochemical staining pattern, we concluded that the metastatic focus in the lymph node was of nasopharyngeal origin. Synchronous occurrence of thyroid carcinoma and nasopharyngeal carcinoma with metastases in the same lymph node following chemotherapy for mantle cell lymphoma was extremely rare. Search of available literature showed one case report of nasopharyngeal carcinoma metastasizing to normal thyroid [8] , but no reported case of synchronous thyroid and nasopharyngeal carcinomas metastasizing to lymph node. Since there was no family history of malignancy in this patient, we surmised that chemotherapy to the mantle cell lymphoma may have altered the immunologic response in this patient to allow subsequent development of two different carcinomas. 
